NeuroPace, Inc.

NASDAQ:NPCE

Medical - Devices

Healthcare
$8.14 +0.30%

+$0.05 today

Market cap
$280.44M
Beta
1.88
P/E (TTM)
-23.8
EPS (TTM)
-$0.64
52W Low $7.56High $19.60

Volume 0.35M

Average 0.18M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$11.01M

FY 2025 · Annual

Investing Cash Flow

-$332,000.00

FY 2025 · Annual

Financing Cash Flow

$19.60M

FY 2025 · Annual

+353.0% YoY

Cash Flow Statement

USD
Metric
FY 2021
Dec 2021
FY 2022
Dec 2022
FY 2023
Dec 2023
FY 2024
Dec 2024
FY 2025
Dec 2025
Net Income(36.08M)(47.08M)(32.96M)(27.14M)(21.47M)
Depreciation & Amortization296K2.99M1.61M1.77M1.95M
Deferred Income Tax5.48M0000
Stock-Based Compensation4.29M8.35M9.56M10.28M11.09M
Change in Working Capital368K(4.79M)(2.48M)(5.45M)(4.01M)
Accounts Receivables1.3M(391K)(4.85M)(537K)(1.83M)
Inventory(1.16M)(2.13M)(1.7M)251K(3.67M)
Accounts Payables479K647K240K671K(730K)
Other Working Capital(259K)(2.91M)3.82M(5.84M)2.22M
Other Non-Cash Items1.07M3.67M4.58M2.59M1.43M
Operating Cash Flow(24.58M)(36.87M)(19.7M)(17.95M)(11.01M)
Capital Expenditures(384K)(603K)(173K)(306K)(332K)
Acquisitions (Net)00000
Purchases of Investments(85.01M)0000
Sales of Investments024.4M23.2M9.3M0
Other Investing Activities00000
Investing Cash Flow(85.4M)23.8M23.03M8.99M(332K)
Debt Repayment(4.09M)000(2.07M)
Common Stock Issued109.09M07.89M3.28M71.76M
Common Stock Repurchased0000(49.55M)
Dividends Paid00000
Other Financing Activities(2.47M)490K239K1.05M(543K)
Financing Cash Flow102.53M490K8.13M4.33M19.6M
Effect of Forex Changes00000
Net Change in Cash(7.45M)(12.58M)11.45M(4.63M)8.26M
Free Cash Flow(24.96M)(37.47M)(19.87M)(18.26M)(11.34M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$21.5M
+ D&A$1.9M
+ Stock-Based Comp$11.1M
+ Deferred Tax$0
- Working Capital-$4.0M
+ Other Non-Cash$1.4M
= Operating Cash Flow-$11.0M
- Capex-$332.0K
= Free Cash Flow-$11.3M

Analysis

FY2025 free cash flow is -$11.3M. FCF conversion is 52.8% of net income. Operating cash flow was -$11.0M, with capex of -$332.0K. The largest bridge item is Stock-Based Comp at $11.1M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
4Statement of changes in beneficial ownershipSep 25, 2026
4Statement of changes in beneficial ownershipSep 21, 2026
4Statement of changes in beneficial ownershipSep 4, 2026

Does NPCE generate free cash flow?

NeuroPace, Inc. (NPCE) generated -$11.34M of free cash flow in fiscal 2025.

How much operating cash flow does NPCE produce?

Operating cash flow was -$11.01M, before capital expenditures of $332,000.00.